Vial

INDIVIDUAL TEST 093

MAG Antibodies

Indication

Suspicion of Inflammatory neuropathy

Sample material

Serum

  • Minim. volume: 0,5 mL

CSF

  • Minim. volume: 0,5 mL

Transport

Within Sweden

  • room temperature

International

  • cold

Method

ELISA

Reference interval

Serum

  • < 30 % negative

CSF

  • < 1000 U/mL negative

Result

Serum

  • results are reported as negative, borderline, or positive with a value

CSF

  • results are reported as negative or positive with a value

Interpretation

Myelin-associated glycoprotein (MAG) is a transmembrane glycoprotein that is located in the myelin skins adjacent to the axon. MAG constitutes a very small part (0.1-1%) of the total protein content of myelin.

Several different forms of motor and sensory neuropathies have been shown to be associated with IgM antibodies to MAG. High levels of antibodies against MAG have been observed in demyelinating motor and sensory neuropathies, low levels have been reported in multiple sclerosis, inflammatory neuropathies and motor neuron diseases. About half of the patients with monoclonal IgM gammopathies with associated neuropathy have antibodies against MAG. The antibodies are usually detected in serum but can also be seen in CSF. Borderline result has uncertain clinical relevance.

References

  • Jacobs BC et al. IGOS Consortium. J Peripher Nerv Syst. 2017. International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome. PMID: 28406555
  • Shang P et al. J Neurol. 2021. Axonal variants of Guillain-Barré syndrome: an update. PMID: 32140865
  • Sheikh AB et al. J Neuroimmunol. 2021. Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review. PMID: 33895700
  • Van den Bergh PYK et al. J Peripher Nerv Syst. 2021. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. PMID: 34085743
  • Wijdicks EF, Klein CJ. Mayo Clin Proc. 2017. Guillain-Barré Syndrome. PMID: 28259232
  • Willison HJ et al. Lancet. 2016. Guillain-Barré syndrome. PMID: 26948435

Last updated: 2024-08-13

More information

Learn more about sampling.
> Read more

Download request forms

Neurology

Can't find what you're looking for? We are here to help

Vial

ENSKILD ANALYS 093

MAG-antikroppar

Indikation

Misstanke om Inflammatorisk neuropati

Provmaterial

Serum

  • Minim. volym: 0,5 mL

Likvor

  • Minim. volym: 0,5 mL

Transport

Inom Sverige

  • rumstemperatur

Internationellt

  • kylt

Metod

ELISA

Referensintervall

Serum

  • < 30 % negativt

Likvor

  • <1000 U/mL negativt

Resultat

Serum

  • resultat anges som negativt, gränsvärde eller positivt med värde.

Likvor

  • resultat anges som negativt eller positivt med ett värde.

Tolkning

Myelinassocierat glykoprotein (MAG) är ett transmembran glykoprotein som är lokaliserat i myelinskidorna i anslutning till axonet. MAG utgör en mycket liten del (0,1-1%) av det totala proteininnehållet i myelin. Flera olika former av sensoriska och sensorimotoriska neuropatier har visats vara associerade med IgM-antikroppar mot MAG.

Hög nivå av antikroppar mot MAG har observerats vid demyeliniserande sensorimotoriska neuropatier. Omkring hälften av patienterna med monoklonal IgM-gammopati med associerad neuropati har antikroppar mot MAG. Antikropparna påvisas vanligen i serum, men kan ibland även ses i CSF. Gränsvärden har tveksam klinisk betydelse.

Referenser

  • Jacobs BC et al. IGOS Consortium. J Peripher Nerv Syst. 2017. International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome. PMID: 28406555
  • Shang P et al. J Neurol. 2021. Axonal variants of Guillain-Barré syndrome: an update. PMID: 32140865
  • Sheikh AB et al. J Neuroimmunol. 2021. Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review. PMID: 33895700
  • Van den Bergh PYK et al. J Peripher Nerv Syst. 2021. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. PMID: 34085743
  • Wijdicks EF, Klein CJ. Mayo Clin Proc. 2017. Guillain-Barré Syndrome. PMID: 28259232
  • Willison HJ et al. Lancet. 2016. Guillain-Barré syndrome. PMID: 26948435

Senast uppdaterat: 2024-08-13

Mer information

Mer information om provtagning.
> Läs mer

Ladda ner remiss

Neurologi

Hittar du inte vad du söker? Vi kan hjälpa till